Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information


EU orphan designation number: EU/3/01/022
Active ingredient: Laronidase
Indication: Treatment of Mucopolysaccharidosis, type I
Sponsor: Genzyme Europe B.V.
Gooimeer 10, 1411 DD Naarden, Nederland
EU Centralised marketing authorisation: A centralised EU marketing authorisation has been obtained under the name Aldurazyme on 10/06/2003 with the number EU/1/03/253

   Public summary of scientific opinion     EPAR

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
22/02/2001 Orphan designation EMEA/OD/042/00 (2001)360 of 14/02/2001
12/06/2013 Removal of orphan designation from Community Register